How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Micron Technology Inc. | €735.50 | €1,293.1 |
| Delta Air Lines Inc. | €75.60 | €72.89 |
| Aerovironment | €130.00 | €257.49 |
| Security | Price | Target price |
|---|---|---|
| Veganz Group AG | €2.18 | - |
| Jetblue Airways Corp. | €4.88 | €3.44 |
| Factset Research Systems | €228.70 | €187.60 |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Circus SE | blaugold | 17.58% |
| B Minimax Group Inc. | michaelkr | 14.37% |
| B Minimax Group Inc. | michaelkr | 11.02% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Veganz Group AG | blaugold | -44.72% |
| S Veganz Group AG | thomasw | -27.55% |
| S Q32 Bio Inc. | thomasw | -25.91% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
A.D.S.....9
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
Biogen Inc.
WKN: 789617 / Symbol: BIIB / Name: Biogen / Stock / Pharmaceuticals / Large Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Robert Half International | €35.97 | 12.340% |
| Abbott Laboratories | €86.42 | 10.910% |
| Perrigo Co. plc | €9.56 | 8.120% |
| Cintas Corp. | €179.84 | 7.190% |
| J.B. Hunt Transport Services Inc. | €257.80 | 6.970% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Corning Inc. | €135.20 | -11.240% |
| Western Digital Corp. | €398.85 | -10.930% |
| Seagate Technology.Holdings plc | €650.00 | -9.970% |
| Intel Corp. | €83.52 | -7.020% |
| Micron Technology Inc. | €735.50 | -6.970% |
Courses
sharewise advanced features
Also you get more information about our Pro and Cons feature, where we bring the wisdom of crowds to a new level.
For discussing with your friends and managing your investment clubs we will show you how to create your own stock debates.#
Get started on the stock market in these easy steps
Things you will learn:
- What is a stock
- What is a fund
- What is an ETF
- How to open a depot
- How to manage a depot that will regularly beat managed funds
- Why you mostly need patience to succeed on the stock market
Predictions
Top News
Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
Key Points
- Interested in Abbott Laboratories? Here are five stocks we like better.
- Abbott Laboratories posted solid Q2 results, with 13% reported growth and 4.8% organic growth, showing Exact
Revving Up Returns: Big Banks Race Through the Rate Plateau
Key Points
- Interested in JPMorgan Chase & Co.? Here are five stocks we like better.
- Despite broad second-quarter 2026 earnings beats, Bank of America, JPMorgan, Goldman Sachs, and Wells Fargo
State Street Q2 Earnings Call Highlights
Key Points
- Interested in State Street Corporation? Here are five stocks we like better.
- State Street posted strong Q2 2026 results, with earnings per share of $3.65 versus $2.17 a year ago and
Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
Key Points
- Interested in Uber Technologies, Inc.? Here are five stocks we like better.
- Uber Technologies is proposing to acquire Delivery Hero for roughly $12.8 billion, valuing shares between
Virtuix Eyes Growth From Meta Quest Launch, Defense Training Push
Key Points
- Interested in Virtuix Holdings Inc.? Here are five stocks we like better.
- Virtuix is getting a boost from its Meta Quest launch, with CEO Jan Goetgeluk saying Omni One for Quest is
Reasons to Retain Alignment Healthcare Stock in Your Portfolio for Now
Alignment Healthcare ALHC is benefiting from automation and AI investments, which are improving operational efficiency, lowering SG&A expenses and expanding margins. The company's strong balance
JBHT Q2 Earnings Beat on Intermodal Growth and Cost Discipline
J.B. Hunt Transport Services, Inc. JBHT reported second-quarter 2026 earnings of $1.91 per share, up 45.8% from $1.31 a year ago. The figure beat the Zacks Consensus Estimate of $1.71 by 11.7%.
Can QUBT's Commercial Growth Focus Maintain Momentum in Q2
Following the strategic acquisitions of Luminar Semiconductor and NuCrypt, Quantum Computing Inc. QUBT or QCi entered the second quarter of 2026 with a focus on transitioning from a technology
3 Reasons Why Growth Investors Shouldn't Overlook CBOE (CBOE)
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to
3 Reasons Why Growth Investors Shouldn't Overlook FMC Technologies (FTI)
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock
Brinker International (EAT) is an Incredible Growth Stock: 3 Reasons Why
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock
News
3 Reasons Why Growth Investors Shouldn't Overlook Alphabet (GOOG)
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to
Here is Why Growth Investors Should Buy Yum China (YUMC) Now
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to
Here's Why You Should Add INKT Stock to Your Portfolio Now
MiNK Therapeutics INKT is focused on developing off-the-shelf allogeneic invariant natural killer T (iNKT) cell therapies for the treatment of life-threatening diseases driven by immune dysfunction
Can Humana (HUM) Run Higher on Rising Earnings Estimates?
Humana (HUM) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its
UnitedHealth Tops Q2 Earnings on Cost Control, Raises '26 Outlook
UnitedHealth Group Incorporated UNH reported second-quarter 2026 adjusted earnings per share (EPS) of $6.38, which beat the Zacks Consensus Estimate of $4.94. The bottom line rose 56.4% year over
Marsh Partners With American Beacon to Expand Advisor Solutions
Marsh & McLennan Companies, Inc. MRSH is expanding its investment offerings through its Mercer business by partnering with American Beacon Advisors to launch a new suite of model portfolio
Sector ETFs to Win on Q2 Earnings Growth Potential
The Q2 earnings season has gathered pace this week, with nearly 70 companies, including 29 S&P 500 members, set to report. The spotlight was on major banks, alongside bellwethers such as Netflix
Will AptarGroup (ATR) Beat Estimates Again in Its Next Earnings Report?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider AptarGroup
Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Exelixis (EXEL), which belongs to the Zacks
Contest
Still running
sharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobieren
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.